If confirmed in further research, particularly in a prospective study with sufficient incidence of T2D and CVD over time, the findings in these two studies suggest that the APOE rs439401 TT-genotype might be used to identify persons at high risk of developing T2D and/or CVD who might be targeted for preventive interventions. Here, APOE is linked to type 2 diabetes mellitus.